In Uncategorized Posted
Open calls TRANSVAC2
The European Vaccine Infrastructure project, TRANSVAC2 led by the European Vaccine Initiative (EVI) has two open calls that provides researchers with an opportunity to access these services and [...]
The European Vaccine Infrastructure project, TRANSVAC2 led by the European Vaccine Initiative (EVI) has two open calls that provides researchers with an opportunity to access these services and [...]
The draft programme of the annual TBVI meeting, will be held in Les Diablerets, Switzerland from 18 – 20 January 2022 is available here.
The WHO published the Global TB Report 2021. This report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the [...]
New TB vaccines are on the horizon, but their success is not guaranteed. World leaders pledged to deliver at least USD $2 billion annually for TB research, including vaccines, at the 2018 United [...]
The STriTuVaD Consortium is proud to announce the recruitment of the First Patient in the STriTuVaD Clinical Trial of RUTI® Vaccine for Tuberculosis (TB). Please read the press release
2021 Pipeline Report Tuberculosis Vaccines
From 20-22 April 2021 the virtual Global Forum on Tuberculosis (TB) Vaccines took place. Please read the meeting report.
We are delighted to announce that TBVI will once again organize its annual meeting in the Swiss mountains of Les Diablerets from 18-20 January 2022. We are currently compiling the program and [...]
Zendal and IAVI announce to partner to advance the tuberculosis vaccine candidate MTBVAC into efficacy trials. For more information, please read the Press Release
a vacancy for a Project Manager at European Vaccine Initiative (EVI). It will be a full time position in Germany. For more information, please read the Job vacancy at the EVI website
Runderweg 6
8219 PK Lelystad
The Netherlands
Email: info@tbvi.eu
Phone: +31 320 277 550